World: Gavi to propose new incentives aimed at advancing vaccine manufacturing in Africa

Country: World Source: GAVI Alliance Gavi, the Vaccine Alliance today announced that it will seek Board approval to deploy US$ 189 million to support the rapid development of Africa’s vaccine manufacturing ecosystem Funding is intended to super-charge Gavi’s African Vaccine Manufacturing Accelerator (AVMA) by tackling bottlenecks and procuring up to 70 million vaccine doses from start-up manufacturers Gavi CEO Dr Sania Nishtar: “With AVMA expected to begin disbursing cash to manufacturers in the second half of this year, we believe these additional funds will provide powerful impetus towards catalysing a successful and sustainable vaccine manufacturing sector in Africa.” Geneva, 15 May 2026 – With Gavi’s African Vaccine Manufacturing Accelerator (AVMA) expected to make its first cash disbursement to an African vaccine manufacturer in the second half of 2026, Gavi, the Vaccine Alliance today proposes further measures totaling US$ 189 million of additional investment to further aid development of Africa’s vaccine manufacturing sector. The measures, named AVMA+, are slated to be presented to Gavi’s Board in July. AVMA+ has been designed to provide additional support in two key areas, firstly addressing specific regulatory and market entry bottlenecks that are acting as a brake on investment and secondly by providing guaranteed demand to African producers by directly purchasing up to 70 million doses of African-manufactured vaccines, following competitive tender processes, once those vaccines reach the market. “In its first 18 months, AVMA has made remarkable progress, helping secure thirteen individual technology transfer agreements that have led to commercial-scale manufacturing facilities being built in six African countries,” said Dr Sania Nishtar, CEO of Gavi, the Vaccine Alliance . “As our manufacturing par...

Original source: Relief Web